Literature DB >> 947199

[Regulation of lipid and carbohydrate metabolism of the heart by carbocromen (author's transl)].

E Schraven.   

Abstract

The influence of 3-(2-diethylaminoethyl)-4-methyl-7-(carbethoxy-methoxy)-2-oxo-1,2-chromene-hydrochloride (carbocromen, Intensain) on lipid and carbohydrate metabolism of the heart was investigated. Carbocromen inhibits the incorporation of 14C-palmitate in heart slices of the rat. The degree of inhibition is dose-dependent and can reach a maximum of 30%. However, the relative concentrations of the various lipid components do not vary significantly. In the heart tissue of the mouse carbocromen increases the uptake of 14C-3-O-methyl-D-glucose by about 30% which might be due to an increased influx of glucose into the heart. The metabolic degradation of 14C-palmitate to 14CO2 decreases up to 40% in the presence of carbocromen with a parallel reduction in oxygen consumption.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 947199

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  Intracoronary infusion of small doses of nifedipine lowers regional myocardial O2-consumption without altering regional myocardial function.

Authors:  P D Verdouw; F J ten Cate; J M Hartog; M G Scheffer; H Stam
Journal:  Basic Res Cardiol       Date:  1982 Jan-Feb       Impact factor: 17.165

2.  Effects of carbocromene on performance and oxidation of FFA and glucose in isolated atria.

Authors:  K Süsskand; J R Sauter; M Siess
Journal:  Basic Res Cardiol       Date:  1980 Jan-Feb       Impact factor: 17.165

3.  Treatment of haemodynamic and electrocardiographic side-effects resulting from imipramine toxicity in rats and dogs.

Authors:  V B Fiedler; B Kettenbach; H Göbel; R E Nitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

4.  The cardiodynamic and metabolic effects of carbochromen and propranolol on the isolated dog heart.

Authors:  J Simaan; G Fawaz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.